Semaglutide and tirzepatide work, but compounded versions during shortages can vary wildly in strength, from half to ten times the intended dose, because they often skip third-party testing. Photograph your peptide label front and back and verify it before using.
Because these drugs, semiglutide, tirzepatide, the GLP1, agony, they all work.
Yep.
And when you say microdosing, and this is bothersome to me, I'll tell you, I, I know this happens is during the compounding, you know, situations when there was a shortage and the compounding pharmacies were helping out, you know, just like your husband's doing, you know, cleaning products. How much third party testing was done on the, the strength or concentration of the compounded substance you were getting? Like, you know, it could be half as strong. Yeah. The right strength, it could be 10 times, and you would have no idea. And the FDA finally sent something out like, and busted somebody for using peptides that said for research only, which is what you use in the lab, not in humans. And I was just like, you know, people always ask me, Regina, they're like, hey, can I take this? And I'm like, well, first of all, take a picture of it and send it to us and then take a picture of the back so we can see what it says. And, you know, let me send me stuff. It says research only. I'm like, no, no.
Yeah. Screen door on a submarine.
That's just
crazy.
